pancreatic cancer proton beam therapy

Tumours of the digestive tract

Treatment of cancer to the liver, pancreas and oesophagus- Proton beam therapy

Pancreatic cancer proton beam using conventional treatments of these serious cancer diseases statistics show there often arises a high likelihood of the tumour returning within a period of up to 5 years.

Results produced by proton centres in the USA show that proton therapy has the benefit delivering a high targeted dose to the tumour while at the same time minimising radiation dose to surrounding healthy tissue. Proton therapy provides the safest and most effective treatment for this type of disease.

Proton therapy in the treatment of tumours of the pancreas, liver cancer and oesophagus provides:

The possibility of applying a higher dose to the tumour

Significant reduction of exposure to surrounding healthy tissue

Compared with conventional radiation therapy allows proton therapy:

Reducing unwanted exposure of the spinal cord by 78%

Reduction in unwanted exposure of the liver by 55%

Reducing unwanted exposure kidneys by 23%

more about the treatment of pancreatic cancer:



Proton results Pancreas

Cancer of the pancreas Proton treated

Conventional radiotherapy Pancreas

Pancreas treated with conventional radiation








Proton therapy Irradiation                                                                                         Pancreas by conventional radiation                 

Tumours of the pancreas are probably the most severe cancer affecting the digestive tract. Unfortunately often by the time it’s diagnosed it has already developed/spread to secondary  sites – metastases. The risk of developing liver metastases are high and it can also spread to the peritoneum or lungs. In these cases there is only one treatment option – chemotherapy. In cases where metastasis  has not developed there are wider therapeutic options.

In some severe cases removal of either the entire pancreas or at least the half can be the only viable option.

However often when the tumour grows beyond the pancreas options then become fundamentally limited. The surgeon will decide in each case whether the operation can be performed in a more radical way or not. If the tumour invades adjacent abdominal arteries, surgery options are excluded.